Skip to main content
. 2019 Jan 7;2019(1):CD009841. doi: 10.1002/14651858.CD009841.pub3

3. Outcomes for age subgroups in R117H study at 24 weeks.

  Overall 6 ‐ 11 years ≥18 years
  Treatment difference P value Treatment difference P value Treatment difference P value
Quality of life (CFQ‐R) ‐ respiratory domain (pooled) 8.4 0.009 ‐6.1 0.19 12.6 0.002
% predicted FEV1 ‐ absolute change from baseline 2.1 0.20 ‐6.3 0.03 5.0 0.01
% predicted FEV1 ‐ relative change from baseline 5.0 0.06 ‐6.8 0.04 0.2 0.008
BMI ‐ absolute change from baseline 0.26 0.78 ‐0.18 0.87 0.31 0.78
Sweat chloride ‐ absolute change from baseline ‐24.0 <0.0001 ‐27.6 <0.001 ‐21.9 <0.001

Treatment difference was adjusted for age and % predicted FEV1

BMI: body mass index
 CFQ‐R: cystic fibrosis questionnaire ‐ revised
 FEV1: forced expiratory volume in one second